✦ LIBER ✦

Absolute Oral Bioavailability of Traxoprodil in Cytochrome P450 2D6 Extensive and Poor Metabolisers

✍ Scribed by Timothy J. Taylor, Kelly Diringer, Tanya Russell, Karthik Venkatakrishnan, Keith Wilner, Penelope H. Crownover, Lisa J. Benincosa, Dr Megan A. Gibbs

Book ID: 119926755
Publisher: Springer International Publishing AG
Year: 2006
Tongue: English
Weight: 203 KB
Volume: 45
Category: Article
ISSN: 0312-5963
DOI: 10.2165/00003088-200645100-00003

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Inhibition of cytochrome P450 2A6 increa

Inhibition of cytochrome P450 2A6 increases nicotine's oral bioavailability and decreases smoking

✍ Sellers, E 📂 Article 📅 2000 🏛 Nature Publishing Group 🌐 English ⚖ 127 KB

Lack of polymorphism of the conversion o

Lack of polymorphism of the conversion of losartan to its active metabolite E-3174 in extensive and poor metabolizers of debrisoquine (cytochrome P450 2D6) and mephenytoin (cytochrome P450 2C19)

✍ P. Sandwall; M.-W. Lo; B. Jonzon; P. Dalén; C. Furtek; M. Ritter; G. Alván; J. M 📂 Article 📅 1999 🏛 Springer 🌐 English ⚖ 95 KB

P.2.c.037 Assessing the pharmacokinetics

P.2.c.037 Assessing the pharmacokinetics of venlafaxine er 75 mg and desvenlafaxine 50 mg in CYP2D6 extensive and poor metabolisers

✍ C. Kane; A. Nichols; K. Focht; Q. Jiang; S. Preskorn; M. Burczynski 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 107 KB

(237) Effects of 12-hour extended-releas

(237) Effects of 12-hour extended-release hydrocodone/acetaminophen treatment in cytochrome P450 2D6 poor metabolizers

✍ D. Katz; B. Spear; A. Bhathena; D. Grimm; J. Thomas; C. Wang; K. Idler; R. Holle 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 39 KB

Rapid and comprehensive determination of

Rapid and comprehensive determination of cytochrome P450 CYP2D6 poor metabolizer genotypes by multiplex polymerase chain reaction

✍ Rebecca Roberts; Patrick Sullivan; Peter Joyce; Martin A. Kennedy 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 312 KB 👁 1 views

Interaction of drug metabolizing cytochr

Interaction of drug metabolizing cytochrome P450 2D6 poor metabolizers with cytochrome P450 2C9 and 2C19 genotypes modify the susceptibility to head and neck cancer and treatment response

✍ Sunishtha S. Yadav; Munindra Ruwali; Mohan C. Pant; Pragya Shukla; Ram L. Singh; 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 169 KB